KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 203 filers reported holding KITE PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $346,000 | -24.9% | 3,340 | -43.2% | 0.05% | -36.6% |
| Q1 2017 | $461,000 | +93.7% | 5,877 | +10.6% | 0.08% | +15.5% |
| Q4 2016 | $238,000 | -12.8% | 5,313 | +8.7% | 0.07% | -46.2% |
| Q3 2016 | $273,000 | +11.9% | 4,889 | 0.0% | 0.13% | -27.1% |
| Q2 2016 | $244,000 | +34.8% | 4,889 | +24.1% | 0.18% | -27.3% |
| Q1 2016 | $181,000 | – | 3,940 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|